Abstract 154P
Background
The variants of urothelial carcinoma such as micropapillary (MP), plasmacytoid (PC), and lipid cell (LC) carry a very poor prognosis. High progression speed and resistance to chemotherapy are considered to be part of the reasons for poor prognosis. Accordingly, early diagnosis and early treatment are important to improve prognosis. In this study, we elucidated the cytological diagnostic criteria of these variants, and also investigated whether preoperative urine cytology could diagnose these variants and the possible association between cytological predictability and pathological features.
Methods
Between April 2015 and March 2020, 45 patients were histologically diagnosed as MP, PC, and LP by TURBT in our institution. The experienced cytologists (YW) in our hospital re-evaluated the preoperative urine cytology in these cases to determine whether or not the prediction of the variant histology is possible. The following findings were used as criteria, small papillary cell clumps with strong binding in MP, circular atypical cells similar to plasma cells in PC, and atypical cells similar to lipoblasts with empty cells in LC. Additionally, we analyzed whether histopathological findings such as muscle invasion, tumor size, tumor necrosis, lymphovascular invasion (LVI), CIS, affect the prediction of the variants.
Results
Of 45 cases, MP, PC and LC were 18 (40%), 13 (29%) and 14 (31%) patients, respectively. 3 cases of MP (17%), 5 of PC (38%) and 2 of LC (14%) could be predicted by re-evaluating preoperative urine cytology. In addition, positive preoperative urine cytology (class 4 or higher) was found in 14 cases in MP (78%), 8 cases in PC (62%), and 11 cases in LC (79%), with estimated probabilities of 21%, 62%, and 18%, respectively. Pathological features were not different between the predictable and unpredictable cases: muscle invasion, 90% vs 74% (P = 0.26); median tumor size, 31 mm vs 38 mm (P = 0.37); tumor necrosis, 20% vs 28% (P = 0.64); LVI, 60% vs 45% (P = 0.42); CIS, 40% vs 34% (P = 0.74), respectively.
Conclusions
Although in some cases, atypical cells suggesting UC variants appeared in the urine cytology, this study suggested that the preoperative cytological diagnosis of bladder cancer variants seems to be difficult.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
187P - BUB1 (2530C>T) polymorphism and expression affects chemotherapy response and predicts poor prognosis in advanced epithelial ovarian cancer
Presenter: Sinjini Sarkar
Session: Poster viewing 03
188P - Spatial transcriptomic analysis of tumor tissue in ovarian cancer patients treated with neoadjuvant chemotherapy
Presenter: Irina Larionova
Session: Poster viewing 03
189P - LncRNA NKILA as a negative regulator of NFkB in ascites in ovarian cancer
Presenter: Dinara Dolgova
Session: Poster viewing 03
190P - Real-world applications of poly (ADP-ribose) polymerase inhibitors for ovarian cancer: A single-center study in China
Presenter: dengfeng wang
Session: Poster viewing 03
191P - Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer
Presenter: N Thejeswar
Session: Poster viewing 03
192P - Human epididymis protein 4 as a predictor of response to neoadjuvant chemotherapy in epithelial ovarian cancer
Presenter: Sarada Planjery
Session: Poster viewing 03
193P - Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice: Experience of re-challenge mode of olaparib usage
Presenter: Alexander Sultanbaev
Session: Poster viewing 03
194P - A study of the treatment response of concomitant external beam radiotherapy (EBRT) and intracavitary brachytherapy in the management of locally advanced carcinoma of uterine cervix
Presenter: Asish Chowdhury
Session: Poster viewing 03
195P - Awareness of human papillomavirus (HPV) infection, cervical cancer (CC), and vaccine among females in Sultanate of Oman
Presenter: Abdulrahman Al-Mirza
Session: Poster viewing 03
196P - Short course brachytherapy in locally advanced cervical cancer: Safety and response rate
Presenter: Maryam Garousi
Session: Poster viewing 03